Tag: ResMed study
ResMed: Bi-level therapy can save adherence
June 5, 2018HME News Staff
BALTIMORE - A ResMed-sponsored study shows that shifting patients who are struggling with adherence to a PAP device to a more advanced bi-level device in the first 90 days of treatment is an effective tool in more than half of cases. In the study, ResMed compared 1,496 non-compliant patients who switched to bi-level therapy and found that compliance was achieved by 58.5% of patients who switched before day 60, 54.2% of patients who switched between days 60-90, and 56.8% of patients overall. “Finding...
